BACKGROUND:: The neonatal period eclipses all other epochs of the human life span for
the highest incidence of seizures. Neonatal seizures are most commonly incited by serious …

Background Although phenobarbital (PB) is commonly used as a first-line antiseizure
medication (ASM) for neonatal seizures, in 2015 we chose to replace it with levetiracetam …

Neonatal seizures are the commonest neurological emergency and are associated with
poor neurodevelopmental outcome. While they are generally difficult to diagnose and treat …

Abstract Objective Antiseizure medications (ASMs) remain the mainstay of epilepsy
treatment. These ASMs have mainly been tested in trials in adults with epilepsy, which …

Objective: To survey anti‐epileptic drug (AED) treatment of early‐onset neonatal seizures by
neonatologists and paediatric neurologists. Methods: A self‐administered questionnaire was …

Purpose Seizures are common in term infants with hypoxic–ischemic encephalopathy (HIE)
undergoing therapeutic hypothermia. Although phenobarbital (PHB) is generally considered …

Neonatal seizures are the most prevalent and distinctive sign of neurologic dysfunction in
early life and pose an immense challenge for clinicians. Improvements in neonatal care …

Neonatal period is the most vulnerable time for the occurrence of seizures, and neonatal
seizures often pose a clinical challenge both for their acute management and frequency of …

The majority of neonatal seizures are of acute symptomatic origin, and their occurrence is
associated with higher mortality and morbidity compared with the general population, even if …

Neonatal seizures have unique properties that have proved challenging for both clinicians
and basic science researchers. Clinical therapies aimed at neonatal seizures have proven …